Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer

Anderly C Chueh; Mun-Sem Liew; Prudence A Russell; Marzena Walkiewicz; Aparna Jayachandran; Maud HW Starmans; Paul C Boutros; Gavin Wright; Stephen A Barnett; John M Mariadason; Thomas John

Journal article

Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer

Anderly C Chueh, Mun-Sem Liew, Prudence A Russell, Marzena Walkiewicz, Aparna Jayachandran, Maud HW Starmans, Paul C Boutros, Gavin Wright, Stephen A Barnett, John M Mariadason, Thomas John

Oncotarget | IMPACT JOURNALS LLC | Published : 2017

DOI: 10.18632/oncotarget.18198

University of Melbourne Researchers

John Mariadason Author Medicine - Austin Health

Gavin Wright Author Medicine - St Vincent's Hospital

Stephen Barnett Author Surgery - Austin Health

Prudence Russell Author Radiology

Anderly Chueh Author Medicine - Austin Health

Grants

Awarded by Pfizer Australia Cancer Grant

Funding Acknowledgements

This study was supported in part by Pfizer Australia Cancer Grant WI180223 (MSL), National Health and Medical Research Council Australia Postgraduate Scholarship (MSL); NHMRC Early Career Fellowship (TJ), Victorian Cancer Agency (TJ), Cancer Council Victoria (TJ), Ludwig Institute for Cancer Research (AC), Ontario Institute for Cancer Research (PCB), Terry Fox Research Institute New Investigator Award (PCB), CIHR New Investigator Award (PCB), and the Victorian Government operational infrastructure support program.